UK hospital performs first paediatric surface-mounted magnetic femoral lengthening
Alder Hey Children’s Hospital has completed the UK’s initial paediatric procedure using a surface-mounted motorised telescopic nail to lengthen a thigh bone, producing a measurable functional height increase. The case delivered a 3 cm immediate length gain and allowed the nine-year-old patient to resume normal activities within months. The implant is driven non-invasively by a magnetic activator positioned on the skin. The distraction protocol averaged about 1 mm per day and ran for roughly six weeks, guiding bone formation in the gap. Hospitalisation for the implantation was minimal — the child was discharged in under a week — and the internal nail was removed three to four months after insertion. Weekly physiotherapy and clinical reviews accompanied the distraction phase and consolidation. Specialists measured the leg-length discrepancy at 4 cm post-treatment and anticipate about 6 cm total correction by skeletal maturity without repeated external fixation. The team reports the centre has already applied the technique to three additional paediatric patients and other UK units are preparing to adopt it. Compared with external fixators, the internal magnetic approach reduces pin-site complications, lowers pain scores, and improves cosmesis. The method originated from US device developments but required protocol adjustments to protect growing physes in children. Clinicians caution that some patients may need staged procedures on the lower leg later in growth to equalise lengths fully.
Read Our Expert Analysis
Create an account or login for free to unlock our expert analysis and key takeaways for this development.
By continuing, you agree to receive marketing communications and our weekly newsletter. You can opt-out at any time.
Recommended for you

The London Clinic conducts UK-first long-distance robotic prostate operation
A London-based surgeon operated remotely on a Gibraltar patient using the Toumai Robotic System , sustaining a network delay of 0.06s . The live, two-case trial signals immediate demand for low-latency comms, remote-surgery platforms, and new regulatory frameworks.
UCL and Great Ormond Street engineer functioning oesophageal grafts in pigs
Research teams at UCL and Great Ormond Street Hospital built porcine-derived scaffolds, reseeded them with recipient cells and restored swallowing in transplanted pigs. The work demonstrates a two-month manufacturing path, full early survival for eight recipients and tissue maturity by six months, signalling a possible clinical pathway for children with long-gap oesophageal atresia.
Belfast pilot shows pulsed‑field ablation can speed and simplify AF care
A Belfast cardiac unit has piloted a pulsed‑field ablation system for atrial fibrillation, treating 60 patients and reporting quicker turnover and same‑day discharge. Early results suggest improved procedural efficiency and reduced collateral tissue risk, but longer follow‑up is needed to confirm durability and broad safety.
Neuracle Medical Technology Secures China Approval for Commercial Brain Implant
Neuracle wins regulatory clearance in China for a coin-sized invasive brain implant to restore hand movement, following 18 months of safety testing and trials involving 32 participants . The clearance both validates an early neuroprosthetic category and dovetails with a broader Beijing push — backed by an ~11.6 billion CNY national brain‑science pool and an expanding trial network — to accelerate BCI commercialization across invasive and noninvasive tracks.